`Tel: 571-272-7822
`
`
`
`
`
`
`Paper 17
`Entered: July 7, 2014
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`CONOPCO, INC. dba UNILEVER
`Petitioner
`
`v.
`
`THE PROCTER & GAMBLE COMPANY
`Patent Owner
`_______________
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`_______________
`
`
`Before LORA M. GREEN, GRACE KARAFFA OBERMANN, and
`RAMA G. ELLURU, Administrative Patent Judges.
`
`OBERMANN, Administrative Patent Judge.
`
`
`
`DECISION
`Denying Institution of Inter Partes Review
`37 C.F.R. § 42.108
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`I. INTRODUCTION
`
`Unilever filed a Petition for an inter partes review of claims 6-10, 14, 15,
`
`and 21-23 of U.S. Patent No. 6,451,300 B1 (Ex. 1001, “the ’300 patent”). Paper 2
`
`(“the Petition” or “Pet.”). The Procter & Gamble Company (“P&G”), the owner of
`
`the ’300 patent, timely filed a Preliminary Response. Paper 8 (“Prelim. Resp.”).
`
`We have jurisdiction under 35 U.S.C. § 314. Based on the specific facts presented,
`
`we exercise our discretion, and deny review under 35 U.S.C. § 325(d).
`
`
`
`A. Related Matter: Case IPR2013-00509 (“the 509 proceeding”)
`
`Unilever filed an earlier Petition that sought an inter partes review of
`
`claims 1-25 of the ’300 patent. Conopco, Inc. dba Unilever v. The Procter &
`
`Gamble Co., Case IPR2013-00509 (“IPR2013-00509”), Paper 4 (“the 509
`
`Petition” or “509 Pet.”). We granted review of claims 1-5, 11-13, 16-20, 24, and
`
`25, and denied review of claims 6-10, 14, 15, and 21-23. IPR2013-00509,
`
`Paper 10 (“509 Dec. on Inst.”). Unilever filed an unsuccessful Request for
`
`Rehearing, seeking reconsideration of our decision denying review of claims 6, 14,
`
`and 15. IPR2-13-00509, Paper 12) (Request for Rehearing).
`
`Unilever then filed the instant Petition, challenging the patentability of each
`
`claim that was denied review in the 509 proceeding. Pet. 1. Unilever concurrently
`
`filed a Motion for Joinder requesting that we join the instant Petition with the 509
`
`proceeding. Paper 3 (“Joinder Mot.”).
`
`
`
`B. The ’300 Patent (Ex. 1001)
`
`The ’300 patent is directed to a shampoo composition and method for
`
`providing a combination of anti-dandruff efficacy and conditioning. Ex. 1001,
`
`2:20-22. According to the ’300 patent Specification, “[t]hese shampoos comprise:
`
` 2
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`(A) from about 5% to about 50%, by weight, of an anionic surfactant; (B) from
`
`about 0.01% to about 10%, by weight, of a non-volatile conditioning agent;
`
`(C) from about 0.1% to about 4%, by weight, of an anti-dandruff particulate;
`
`(D) from about 0.02% to about 5%, by weight, of at least one cationic polymer;
`
`(E) from 0.005% to about 1.5%, by weight, of a polyalkylene glycol; and
`
`(F) water.” Id. at 2:22-30. The Specification further defines the polyalkylene
`
`glycol. Id. at 2:30-33.
`
`The Specification sets forth five examples of the inventive shampoo
`
`composition. Id. at 31:50-33:45. The Specification also describes a method for
`
`applying the shampoo to the hair and scalp, which preferably has been wetted with
`
`water, in an amount that is effective to confer anti-dandruff efficacy and hair
`
`conditioning; the shampoo is thereafter rinsed off. Id. at 2:34-37; 31:24-28.
`
`
`
`C. Illustrative Claim
`
`Claim 10, which depends from claims 1 and 2, is illustrative of the claimed
`
`subject matter. Those claims are reproduced below.
`
`A shampoo composition comprising:
`1.
`a) from about 5% to about 50%, by weight of the composition, of an anionic
`surfactant;
`b) from about 0.01% to about 10%, by weight of the composition, of a non-
`volatile conditioning agent;
`c) from about 0.1% to about 4%, by weight of the composition, of an anti-
`dandruff particulate;
`d) from about 0.02% to about 5%, by weight of the composition, of at least
`one cationic polymer;
`e) from 0.005% to about 1.5%, by weight of the composition, of a
`polyalkylene glycol corresponding to the formula:
`
` 3
`
`
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`i) wherein R is selected from the group consisting of hydrogen,
`methyl and mixtures thereof;
`ii) wherein n is an integer having an average value from about 1,500
`to about 120,000; and
`f) water.
`
`A shampoo composition according to claim 1, wherein said at least
`2.
`one cationic polymer component is selected from the group consisting of
`guar derivatives, cellulose derivatives, and mixtures thereof.
`
`10. A shampoo composition according to claim 2, wherein said cellulose
`derivatives have a charge density from about 0.2 meq/g to about 0.6 meq/g.
`
`
`
`D. The Asserted Grounds of Unpatentability
`
`In the instant petition, Unilever challenges claims 6-10, 14, 15, and 21-23 of
`
`the ’300 patent based on the following asserted grounds of unpatentability:
`
`Reference[s]
`
`Kanebo1 and Cothran2
`
`Kanebo, Cseh,3 and Cosmedia4
`
`Kanebo, Reid,5 and Bartolo6
`
`Basis
`
`§ 103
`
`§ 103
`
`§ 103
`
`Claims challenged
`
`6-10
`
`6
`
`6, 8, 9
`
`Kanebo, Cseh, Sime,7 and Cosmedia
`
`§ 103
`
`6
`
`
`1 Kanebo JP 09-188614 (July 22, 1997) (English translation) (Ex. 1006).
`2 Cothran WO 96/32919 (Oct. 24, 1996) (Ex. 1044).
`3 Cseh US 4,676,978 (June 30, 1997) (Ex. 1042).
`4 Cosmedia® Guar C261 (Product Data Sheet) (Ex. 1040).
`5 Reid US 5,085,857 (Feb. 4, 1992) (Ex. 1018).
`6 Bartolo US 5,202,048 (April 13, 1993) (Ex. 1012).
`7 Sime US 5,037,818 (Aug. 6, 1991) (Ex. 1028).
`
` 4
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`Reference[s]
`
`Kanebo, Cardin,8 and Kalla9
`
`Kanebo and Bar-Shalom10
`
`Evans11 and Cothran
`
`Evans, Cseh, and Cosmedia
`
`
`
`Basis
`
`§ 103
`
`§ 103
`
`§ 103
`
`§ 103
`
`Claims challenged
`
`14, 15, 22
`
`21, 23
`
`10
`
`6, 8, 9
`
`The standard for instituting an inter partes review is set forth in 35 U.S.C.
`
`II. ANALYSIS
`
`§ 314(a) as follows:
`
`THRESHOLD -- The Director may not authorize an inter partes review to be
`instituted unless the Director determines that the information presented in
`the petition filed under section 311 and any response filed under section 313
`shows that there is a reasonable likelihood that the petitioner would prevail
`with respect to at least 1 of the claims challenged in the petition.
`
`As set forth in 35 U.S.C. § 325(d), the Director, and by extension the Board,
`
`has broad discretion to deny a petition that raises substantially the same prior art or
`
`arguments previously presented to the Office. That statutory provision provides as
`
`follows:
`
`In determining whether to institute or order a proceeding under this chapter,
`chapter 30, or chapter 31, the Director may take into account whether, and
`reject the petition or request because, the same or substantially the same
`prior art or arguments previously were presented to the Office.
`
`
`8 Cardin US 5,104,645 (Apr. 14, 1992) (Ex. 1014).
`9 Kalla WO 97/026854 (July 31, 1997) (Ex. 1031).
`10 Bar-Shalom US 5,618,798 (Apr. 8, 1997) (Ex. 1034).
`11 Evans WO 97/14405 (Apr. 24, 1997) (Ex. 1010).
`
` 5
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`The instant Petition challenges each claim that was denied review in
`
`the 509 proceeding. Compare 509 Pet. 6-7 with Pet. 9-10 (both raising
`
`obviousness challenges against claims 6-10, 14, 15, and 21-23); see 509 Dec. on
`
`Inst. 18 (denying review of those claims). The instant Petition relies on eleven
`
`pieces of prior art: four that were raised in the 509 Petition (Kanebo, Cardin,
`
`Evans, and Bartolo) and seven that are new to this proceeding (Cothran, Cseh,
`
`Cosmedia, Reid, Sime, Kalla, and Bar-Shalom). Compare 509 Pet. 9-10 with
`
`Pet. 8; 509 Pet. 1, 21, 32, 37 with Pet. 8 (for Bartolo). Unilever, however, presents
`
`no argument or evidence that the seven newly cited references were not known or
`
`available to it at the time of filing of the 509 Petition. Moreover, six grounds rely
`
`on Kanebo, a reference previously presented in the 509 Petition. The two
`
`remaining grounds rely on Evans, a reference previously presented in the 509
`
`Petition. Compare 509 Pet. 9-10 with Pet. 10. On this record, we exercise our
`
`discretion and “reject the petition” because “the same or substantially the same
`
`prior art” previously was “presented to the Office” in the 509 proceeding.
`
`35 U.S.C. § 325(d).
`
`An additional rationale supports our decision. We are persuaded that
`
`arguments raised in the instant Petition are “substantially the same” as those
`
`“previously [] presented to the Office” in the 509 proceeding. Id. Unilever’s
`
`treatment of claim 10 is illustrative. Claim 10 includes all the limitations of
`
`claims 1 and 2 and, further, requires cellulose derivatives within a specified charge
`
`density range.
`
`In the 509 Petition, Unilever argued that Evans discloses each limitation of
`
`claim 10, except for the limitation relating to the charge density, arguing that
`
` 6
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`Coffindaffer12 suggests that missing feature. 509 Pet. 43, 48-49. We found lacking
`
`any persuasive evidence of a reason to combine those references. 509 Dec. on
`
`Inst. 15-16. Unilever now contends that claim 10 would have been obvious over
`
`Evans and Cothran. Pet. 42-47, 53-54. In both petitions, Unilever advances
`
`“substantially the same” argument—namely, that claim 10 would have been
`
`obvious over Evans in view of other art disclosing cellulose derivatives that
`
`overlap or fall within the specified charge density range. 35 U.S.C. § 325(d).
`
`Similarly, claim 15 includes all the limitations of claim 1 and, further,
`
`requires an anti-dandruff particulate having an “average particulate size of
`
`about 2.5 µm.” In the 509 Petition, Unilever argued that Kanebo discloses each
`
`limitation of claim 15, except for the limitation relating to “average particulate
`
`size,” arguing that Cardin discloses that missing feature. 509 Pet. 50-52. We
`
`denied review on the ground that Unilever provided only “conclusory arguments”
`
`supporting the proposed combination of prior art. 509 Dec. on Inst. 15-16.
`
`Unilever now contends that claim 15 would have been obvious over Kanebo,
`
`Cardin, and Kalla. Pet. 34-37. Unilever relies on Kalla in support of its reason to
`
`combine, and in particular, for a disclosure of advantages of using the platelet
`
`particle form of 1-hydroxy-2pyridinethione salts, having the specified particle size
`
`range, as the antimicrobial agent in a shampoo composition. Pet. 36-37. On this
`
`record, Unilever advances “substantially the same” argument that was previously
`
`asserted in the 509 Petition. 35 U.S.C. § 325(d); compare 509 Pet. 50-52 with
`
`Pet. 34-37.
`
`
`
`We have considered all of the papers filed in both proceedings. Based on
`
`the information presented, we are persuaded that the instant Petition uses our prior
`
`
`12 Coffindaffer US 5,624,666 (April 29, 1997).
`
` 7
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`Decision on Institution to bolster challenges that were advanced, unsuccessfully, in
`
`the 509 Petition. Specifically, Unilever argues that the instant Petition “obviates
`
`purported deficiencies” illuminated in our prior decision. Joinder Mot. 8. P&G,
`
`on the other hand, contends that Unilever seeks to revive and augment challenges
`
`that were rejected in the 509 proceeding, “[a]rmed with the Board’s guidance as to
`
`the flaws in the [509 Petition].” Prelim. Resp. 7. On this record, we determine that
`
`the instant Petition presents “the same or substantially the same prior art or
`
`arguments” that were advanced in the 509 Petition. 35 U.S.C. § 325(d).
`
`Unilever has not presented considerations that tip the balance in favor of
`
`review. Given that we already have considered the same or substantially the same
`
`prior art or arguments in connection with the challenged claims, we deny the
`
`request for an inter partes review under § 325(d). We deny the motion for joinder
`
`as moot.
`
`
`
`It is
`
`III. ORDER
`
`ORDERED that the Petition is denied at to all challenged claims of
`
`the ’300 patent;
`
`FURTHER ORDERED that Unilever’s Motion for Joinder with IPR2013-
`
`00509 is denied as moot.
`
`
`
`
`
`
`
` 8
`
`
`
`
`
`
`
`Case IPR2014-00507
`Patent 6,451,300 B1
`
`
`PETITIONER:
`
`Eldora Ellison
`Eellison-PTAB@skgf.com
`
`Robert Sterne
`Rsterne-PTAB@skgf.com
`
`
`
`PATENT OWNER:
`
`David Maiorana
`dmaiorana@jonesday.com
`
`John Biernacki
`jvbiernacki@jonesday.com
`
`Michael Weinstein
`mweinstein@jonesday.com
`
`Steven Miller
`Miller.sw@pg.com
`
`Kim Zerby
`Zerby.kw@pg.com
`
`Carl Roof
`Roof.cj@pg.com
`
`Angela Haughey
`Haughey.a@pg.com
`
`
` 9
`
`
`
`
`
`